What's new

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Mar 21, 2025 - 11:33
 0
Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn
Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn
Read More

Tags:

Previous Article

Autoglym launches new training courses for workshops

Next Article

Human medicines European public assessment report (EPAR): Mycapssa, octreotide, ...

Related Posts

Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

Info session on web-based electronic Application Form (eAF) add package, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 July 2024, 11:00 (CEST) to 18 July 2024, 12:00 (CEST)

Info session on web-based electronic Application Form (...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Drovelis, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0